APP and Aβ immunoreactivity has been detected in an age-dependent manner [80] in the retinas of AD patients, and, even more excitingly (in terms of finding a retinal biomarker for AD), Aβ plaques have been demonstrated as a postmortem finding in the retinas of AD patients [70]. This evidence concerns the gene APP and Alzheimer disease.